|
1
|
Peschke E, Bähr I and Mühlbauer E:
Experimental and clinical aspects of melatonin and clock genes in
diabetes. J Pineal Res. 59:1–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Simonis-Bik AM, Nijpels G, van Haeften TW,
Houwing-Duistermaat JJ, Boomsma DI, Reiling E, van Hove EC, Diamant
M, Kramer MH, Heine RJ, et al: Gene variants in the novel type 2
diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B
affect different aspects of pancreatic beta-cell function.
Diabetes. 59:293–301. 2010. View Article : Google Scholar
|
|
3
|
Lyssenko V, Nagorny CL, Erdos MR, Wierup
N, Jonsson A, Spégel P, Bugliani M, Saxena R, Fex M, Pulizzi N, et
al: Common variant in MTNR1B associated with increased risk of type
2 diabetes and impaired early insulin secretion. Nat Genet.
41:82–88. 2009. View
Article : Google Scholar
|
|
4
|
Rönn T, Wen J, Yang Z, Lu B, Du Y, Groop
L, Hu R and Ling C: A common variant in MTNR1B, encoding melatonin
receptor 1B, is associated with type 2 diabetes and fasting plasma
glucose in Han Chinese individuals. Diabetologia. 52:830–833. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stehle JH, Saade A, Rawashdeh O, Ackermann
K, Jilg A, Sebestény T and Maronde E: A survey of molecular details
in the human pineal gland in the light of phylogeny, structure,
function and chronobiological diseases. J Pineal Res. 51:17–43.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sharma S, Singh H, Ahmad N, Mishra P and
Tiwari A: The role of melatonin in diabetes: Therapeutic
implications. Arch Endocrinol Metab. 59:391–399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagorny CL, Sathanoori R, Voss U, Mulder H
and Wierup N: Distribution of melatonin receptors in murine
pancreatic islets. J Pineal Res. 50:412–417. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mühlbauer E, Gross E, Labucay K, Wolgast S
and Peschke E: Loss of melatonin signalling and its impact on
circadian rhythms in mouse organs regulating blood glucose. Eur J
Pharmacol. 606:61–71. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bazwinsky-Wutschke I, Wolgast S, Mühlbauer
E, Albrecht E and Peschke E: Phosphorylation of cyclic AMP-response
element-binding protein (CREB) is influenced by melatonin treatment
in pancreatic rat insulinoma β-cells (INS-1). J Pineal Res.
53:344–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peschke E, Hofmann K, Pönicke K, Wedekind
D and Mühlbauer E: Catecholamines are the key for explaining the
biological relevance of insulin-melatonin antagonisms in type 1 and
type 2 diabetes. J Pineal Res. 52:389–396. 2012. View Article : Google Scholar
|
|
11
|
Bach AG, Mühlbauer E and Peschke E:
Adrenoceptor expression and diurnal rhythms of melatonin and its
precursors in the pineal gland of type 2 diabetic goto-kakizaki
rats. Endocrinology. 151:2483–2493. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim TK, Lee JS, Jung HS, Ha TK, Kim SM,
Han N, Lee EJ, Kim TN, Kwon MJ, Lee SH, et al: Triiodothyronine
induces proliferation of pancreatic beta-cells through the MAPK/ERK
pathway. Exp Clin Endocrinol Diabetes. 122:240–245. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beith JL, Alejandro EU and Johnson JD:
Insulin stimulates primary beta-cell proliferation via Raf-1
kinase. Endocrinology. 149:2251–2260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lawrence MC, Jivan A, Shao C, Duan L, Goad
D, Zaganjor E, Osborne J, McGlynn K, Stippec S, Earnest S, et al:
The roles of MAPKs in disease. Cell Res. 18:436–442. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alejandro EU, Kalynyak TB, Taghizadeh F,
Gwiazda KS, Rawstron EK, Jacob KJ and Johnson JD: Acute insulin
signaling in pancreatic beta-cells is mediated by multiple Raf-1
dependent pathways. Endocrinology. 151:502–512. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Q, Wang R, Zhou H, Zhang L, Cao Y,
Wang X and Hao Y: SHIP2 on pI3K/Akt pathway in palmitic acid
stimulated islet β cell. Int J Clin Exp Med. 8:3210–3218. 2015.
|
|
17
|
Stewart AF, Hussain MA, García-Ocaña A,
Vasavada RC, Bhushan A, Bernal-Mizrachi E and Kulkarni RN: Human
β-cell proliferation and intracellular signaling: Part 3. Diabetes.
64:1872–1885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pardo FN, Altirriba J, Pradas-Juni M,
García A, Ahlgren U, Barberà A, Slebe JC, Yáñez AJ, Gomis R and
Gasa R: The role of Raf-1 kinase inhibitor protein in the
regulation of pancreatic beta cell proliferation in mice.
Diabetologia. 55:3331–3340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Cheng K, Delghingaro-Augusto V, Nolan CJ,
Turner N, Hallahan N, Andrikopoulos S and Gunton JE: High passage
MIN6 cells have impaired insulin secretion with impaired glucose
and lipid oxidation. PloS One. 7:e408682012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mühlbauer E, Albrecht E,
Bazwinsky-Wutschke I and Peschke E: Melatonin influences insulin
secretion primarily via MT(1) receptors in rat insulinoma cells
(INS-1) and mouse pancreatic islets. J Pineal Res. 52:446–459.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peschke E, Wolgast S, Bazwinsky I, Pönicke
K and Muhlbauer E: Increased melatonin synthesis in pineal glands
of rats in streptozotocin induced type 1 diabetes. J Pineal Res.
45:439–448. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nishida S, Segawa T, Murai I and Nakagawa
S: long-term melatonin administration reduces hyperinsulinemia and
improves the altered fatty-acid compositions in type 2 diabetic
rats via the restoration of Delta-5 desaturase activity. J Pineal
Res. 32:26–33. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peschke E, Schucht H and Mühlbauer E:
long-term enteral administration of melatonin reduces plasma
insulin and increases expression of pineal insulin receptors in
both Wistar and type 2-diabetic Goto-Kakizaki rats. J Pineal Res.
49:373–381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ramracheya RD, Muller DS, Squires PE,
Brereton H, Sugden D, Huang GC, Amiel SA, Jones PM and Persaud SJ:
Function and expression of melatonin receptors on human pancreatic
islets. J Pineal Res. 44:273–279. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wentworth BM, Schaefer IM, Villa-Komaroff
L and Chirgwin JM: Characterization of the two nonallelic genes
encoding mouse preproinsulin. J Mol Evol. 23:305–312. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peschke E, Peschke D, Hammer T and Csernus
V: Influence of melatonin and serotonin on glucose-stimulated
insulin release from perifused rat pancreatic islets in vitro. J
Pineal Res. 23:156–163. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Picinato MC, Haber EP, Cipolla-Neto J,
Curi R, de Oliveira Carvalho CR and Carpinelli AR: Melatonin
inhibits insulin secretion and decreases PKA levels without
interfering with glucose metabolism in rat pancreatic islets. J
Pineal Res. 33:156–160. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Frankel BJ and Strandberg MJ: Insulin
release from isolated mouse islets in vitro: No effect of
physiological levels of melatonin or arginine vasotocin. J Pineal
Res. 11:145–148. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peschke E, Bach AG and Mühlbauer E:
Parallel signaling pathways of melatonin in the pancreatic
beta-cell. J Pineal Res. 40:184–191. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peschke E, Stumpf I, Bazwinsky I, Litvak
L, Dralle H and Mühlbauer E: Melatonin and type 2 diabetes - a
possible link? J Pineal Res. 42:350–358. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bonnefond A, Clément N, Fawcett K, Yengo
L, Vaillant E, Guillaume JL, Dechaume A, Payne F, Roussel R,
Czernichow S, et al: Rare MTNR1B variants impairing melatonin
receptor 1B function contribute to type 2 diabetes. Nat Genet.
44:297–301. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Picinato MC, Hirata AE, Cipolla-Neto J,
Curi R, Carvalho CR, Anhê GF and Carpinelli AR: Activation of
insulin and IGF-1 signaling pathways by melatonin through MT1
receptor in isolated rat pancreatic islets. J Pineal Res. 44:88–94.
2008.
|
|
34
|
Vanecek J: Cellular mechanisms of
melatonin action. Physiol Rev. 78:687–721. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stork PJ and Schmitt JM: Crosstalk between
cAMP and MAP kinase signaling in the regulation of cell
proliferation. Trends Cell Biol. 12:258–266. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pearson G, Robinson F, Beers Gibson T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001.PubMed/NCBI
|
|
37
|
Alejandro EU, Lim GE, Mehran AE, Hu X,
Taghizadeh F, Pelipeychenko D, Baccarini M and Johnson JD:
Pancreatic β-cell Raf-1 is required for glucose tolerance, insulin
secretion, and insulin 2 transcription. FASEB J. 25:3884–3895.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kowluru A, Veluthakal R, Rhodes CJ, Kamath
V, Syed I and Koch BJ: Protein farnesylation-dependent
Raf/extracellular signal-related kinase signaling links to
cytoskeletal remodeling to facilitate glucose-induced insulin
secretion in pancreatic beta-cells. Diabetes. 59:967–977. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Boutin JA, Audinot V, Ferry G and
Delagrange P: Molecular tools to study melatonin pathways and
actions. Trends Pharmacol Sci. 26:412–419. 2005. View Article : Google Scholar : PubMed/NCBI
|
